TuHURA Biosciences (HURA) News Today $3.21 0.00 (0.00%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock HURA Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period TuHURA Biosciences: Encountering Serious Cash Issues And A Long TimelineMay 28 at 4:08 PM | seekingalpha.comQ3 EPS Forecast for TuHURA Biosciences Reduced by AnalystTuHURA Biosciences (NASDAQ:HURA - Free Report) - Research analysts at Zacks Small Cap dropped their Q3 2025 earnings estimates for shares of TuHURA Biosciences in a research report issued on Monday, May 19th. Zacks Small Cap analyst J. Vandermosten now anticipates that the company will earn ($0.1May 24, 2025 | marketbeat.comZacks Small Cap Issues Pessimistic Outlook for HURA EarningsMay 24, 2025 | americanbankingnews.comKineta and TuHURA Biosciences Announce Merger AgreementMay 23, 2025 | tipranks.comEquities Analysts Set Expectations for HURA FY2027 EarningsTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities research analysts at Zacks Small Cap issued their FY2027 earnings per share estimates for shares of TuHURA Biosciences in a research report issued to clients and investors on Monday, May 19th. Zacks Small Cap analyst J. Vandermosten forecaMay 23, 2025 | marketbeat.comResearch Analysts Offer Predictions for HURA FY2027 EarningsMay 23, 2025 | americanbankingnews.comWhat is HC Wainwright's Estimate for HURA FY2025 Earnings?TuHURA Biosciences (NASDAQ:HURA - Free Report) - Stock analysts at HC Wainwright issued their FY2025 earnings estimates for TuHURA Biosciences in a research report issued on Friday, May 16th. HC Wainwright analyst R. Burns forecasts that the company will post earnings of ($0.56) per share for theMay 21, 2025 | marketbeat.comWhat is HC Wainwright's Forecast for HURA FY2025 Earnings?May 20, 2025 | americanbankingnews.comHURA: First Quarter 2025 ResultsMay 19, 2025 | finance.yahoo.comTuHURA Biosciences' (HURA) Buy Rating Reiterated at HC WainwrightMay 19, 2025 | americanbankingnews.comTuHURA Biosciences, Inc. Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 15, 2025 | prnewswire.comTuHURA Biosciences, Inc. to Present at the 3rd Annual H.C. Wainwright BioConnect ConferenceMay 13, 2025 | prnewswire.comTuHURA Biosciences (HURA) Projected to Post Earnings on TuesdayTuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Tuesday, May 13. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-13-tuhura-biosciences-stock/)May 8, 2025 | marketbeat.comKineta Amends Merger Agreement with TuHURA BiosciencesMay 7, 2025 | tipranks.comTuHURA Biosciences, Inc. (HURA)May 6, 2025 | finance.yahoo.comInnovative Immune Therapy Approach Drives Buy Rating for TuHURA BiosciencesMay 6, 2025 | tipranks.comTuHURA Biosciences, Inc. Initiates Phase 1b/2a Study of IFx-Hu2.0 as an Adjunctive Therapy to Keytruda® (pembrolizumab) in First Line Treatment for Metastatic Merkel Cell Carcinoma of Unknown Primary Origin (MCCUP)May 5, 2025 | prnewswire.comGeode Capital Management LLC Buys New Holdings in TuHURA Biosciences (NASDAQ:HURA)Geode Capital Management LLC bought a new stake in shares of TuHURA Biosciences (NASDAQ:HURA - Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 264,915 shares of the company's stock, valued at apMay 3, 2025 | marketbeat.comTuHURA And Kineta Present Updated Results From Phase I-II Study Of KVA12123April 30, 2025 | nasdaq.comTuHURA Biosciences: Promising Developments in Anti-VISTA Antibody and DNA-based Immune Activator Justify Buy RatingApril 29, 2025 | tipranks.comTuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure ...April 29, 2025 | seekingalpha.comTuHURA Biosciences and Kineta Present Updated Results from Kineta's Phase I-II Study of KVA12123 and TuHURA's Mechanism of IFx-Hu2.0 Responses After Anti-PD-1 Therapy Failure in Advanced Melanoma at the American Association for Cancer Research Annual MeetingApril 28, 2025 | prnewswire.comIs TuHURA Biosciences, Inc. (HURA) the Best Rising Penny Stock to Buy According to Analysts?April 18, 2025 | insidermonkey.comZacks Small Cap Issues Positive Forecast for HURA EarningsTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities research analysts at Zacks Small Cap increased their Q3 2025 earnings estimates for TuHURA Biosciences in a research report issued to clients and investors on Monday, April 14th. Zacks Small Cap analyst J. Vandermosten now expects that theApril 18, 2025 | marketbeat.comHURA: 2024 Financial ResultsApril 14, 2025 | msn.comTuHURA Biosciences hires new EVP for drug developmentApril 9, 2025 | uk.investing.comTuHURA Biosciences, Inc. Announces Abstracts Accepted for Poster Presentation at the 2025 AACR Annual MeetingApril 8, 2025 | prnewswire.comQ2 EPS Estimate for TuHURA Biosciences Increased by AnalystTuHURA Biosciences (NASDAQ:HURA - Free Report) - Stock analysts at HC Wainwright upped their Q2 2026 earnings per share (EPS) estimates for TuHURA Biosciences in a research note issued on Thursday, April 3rd. HC Wainwright analyst R. Burns now anticipates that the company will post earnings per sApril 8, 2025 | marketbeat.comTuHURA Biosciences, Inc. Appoints Dr. Bertrand Le Bourdonnec as Executive Vice President, Head of Drug Discovery, Early Development, and Program ManagementApril 7, 2025 | prnewswire.comEquities Analysts Set Expectations for HURA Q3 EarningsTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities research analysts at HC Wainwright issued their Q3 2026 earnings per share (EPS) estimates for TuHURA Biosciences in a report issued on Thursday, April 3rd. HC Wainwright analyst R. Burns forecasts that the company will earn ($0.10) per shApril 6, 2025 | marketbeat.comHC Wainwright Cuts TuHURA Biosciences (NASDAQ:HURA) Price Target to $12.00HC Wainwright cut their price objective on shares of TuHURA Biosciences from $13.00 to $12.00 and set a "buy" rating for the company in a report on Thursday.April 5, 2025 | marketbeat.comIs TuHURA Biosciences (NASDAQ:HURA) In A Good Position To Deliver On Growth Plans?April 2, 2025 | finance.yahoo.comTuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year 2024 and Provides Corporate UpdateApril 1, 2025 | prnewswire.comTuHURA Biosciences (NASDAQ:HURA) Stock Price Up 1.7% - Still a Buy?TuHURA Biosciences (NASDAQ:HURA) Shares Up 1.7% - Should You Buy?March 28, 2025 | marketbeat.comTuHURA Biosciences Announces Acquisition of Kineta, Inc.March 18, 2025 | msn.comTuHURA Biosciences appoints Craig Tendler to board of directorsMarch 11, 2025 | markets.businessinsider.comTuHURA Biosciences, Inc. to Present at the 37th Annual ROTH ConferenceMarch 10, 2025 | gurufocus.comQ2 Earnings Estimate for HURA Issued By HC WainwrightTuHURA Biosciences (NASDAQ:HURA - Free Report) - Equities researchers at HC Wainwright issued their Q2 2025 earnings per share estimates for shares of TuHURA Biosciences in a report issued on Monday, March 3rd. HC Wainwright analyst R. Burns expects that the company will earn ($0.20) per share foMarch 7, 2025 | marketbeat.comTuHURA Biosciences initiated with a Buy at H.C. WainwrightMarch 4, 2025 | markets.businessinsider.comHC Wainwright & Co. Initiates Coverage of TuHURA Biosciences (HURA) with Buy RecommendationMarch 4, 2025 | msn.comTuHURA Biosciences (NASDAQ:HURA) Earns Buy Rating from Analysts at HC WainwrightHC Wainwright began coverage on TuHURA Biosciences in a report on Monday. They set a "buy" rating and a $13.00 price objective for the company.March 3, 2025 | marketbeat.comSuncoast Equity Management Buys Shares of 102,997 TuHURA Biosciences (NASDAQ:HURA)Suncoast Equity Management purchased a new position in TuHURA Biosciences (NASDAQ:HURA - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor purchased 102,997 shares of the company's stock,February 22, 2025 | marketbeat.comTuHURA Biosciences (HURA) to Release Earnings on WednesdayTuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Wednesday, February 26, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comTuHURA Biosciences: A Hold On Only The Faintest Glimmers Of EfficacyFebruary 16, 2025 | seekingalpha.comApollon Wealth Management LLC Acquires New Stake in TuHURA Biosciences (NASDAQ:HURA)Apollon Wealth Management LLC acquired a new stake in shares of TuHURA Biosciences (NASDAQ:HURA - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 61,772 shares of the company's stock, valued at approximately $253,000. ApolloFebruary 15, 2025 | marketbeat.comQ2 Earnings Estimate for HURA Issued By Zacks Small CapTuHURA Biosciences (NASDAQ:HURA - Free Report) - Analysts at Zacks Small Cap issued their Q2 2025 earnings estimates for TuHURA Biosciences in a report released on Tuesday, February 4th. Zacks Small Cap analyst J. Vandermosten anticipates that the company will post earnings of ($0.09) per share fFebruary 5, 2025 | marketbeat.comHURA: Initiating an Immune ResponseFebruary 5, 2025 | msn.comTuHURA Biosciences (HURA) Projected to Post Quarterly Earnings on WednesdayTuHURA Biosciences (NASDAQ:HURA) will be releasing earnings before the market opens on Wednesday, February 12, Financial Modeling Prep reports.February 5, 2025 | marketbeat.comTuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6% - Here's What HappenedTuHURA Biosciences (NASDAQ:HURA) Trading Down 2.6% - What's Next?January 31, 2025 | marketbeat.comWhen Can We Expect A Profit From TuHURA Biosciences, Inc. (NASDAQ:HURA)?January 18, 2025 | uk.finance.yahoo.com Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address HURA Media Mentions By Week HURA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HURA News Sentiment▼0.370.87▲Average Medical News Sentiment HURA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HURA Articles This Week▼102▲HURA Articles Average Week Get TuHURA Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for HURA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DAWN News Today TRVI News Today IMTX News Today VIR News Today SION News Today EOLS News Today REPL News Today PHAR News Today DNTH News Today CDXC News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HURA) was last updated on 5/29/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TuHURA Biosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share TuHURA Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HURA Stock Free HURA Stock Alerts